Cargando…
Interleukin-27 Gene Delivery Targeting IL-6Rα-Expressing Cells as a Stress Response Therapy
Interleukin-27 (IL-27) has shown promise in halting tumor growth and mediating tumor regression in several models, including prostate cancer. We describe our findings on the effects of IL-27 on the gene expression changes of TC2R prostate adenocarcinoma cells. We utilized RNAseq to assess profile di...
Autores principales: | Figueiredo Neto, Manoel, Liu, Shengzhi, Salameh, Janelle Wes, Yokota, Hiroki, Figueiredo, Marxa Leão |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038084/ https://www.ncbi.nlm.nih.gov/pubmed/32046108 http://dx.doi.org/10.3390/ijms21031108 |
Ejemplares similares
-
Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo
por: Figueiredo, Marxa L., et al.
Publicado: (2020) -
Combination of Interleukin-27 and MicroRNA for Enhancing Expression of Anti-Inflammatory and Proosteogenic Genes
por: Figueiredo Neto, Manoel, et al.
Publicado: (2017) -
A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications
por: Salameh, Janelle Wesleyn, et al.
Publicado: (2022) -
Enhancing Prednisone-Based Arthritis Therapy with Targeted IL-27 Gene Delivery
por: Marin, Adriana A., et al.
Publicado: (2022) -
Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer
por: Kumar, Shreya, et al.
Publicado: (2023)